JPS6222966B2 - - Google Patents
Info
- Publication number
- JPS6222966B2 JPS6222966B2 JP4989485A JP4989485A JPS6222966B2 JP S6222966 B2 JPS6222966 B2 JP S6222966B2 JP 4989485 A JP4989485 A JP 4989485A JP 4989485 A JP4989485 A JP 4989485A JP S6222966 B2 JPS6222966 B2 JP S6222966B2
- Authority
- JP
- Japan
- Prior art keywords
- tocotrienol
- days
- present
- active ingredient
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940064063 alpha tocotrienol Drugs 0.000 claims description 8
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 claims description 8
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 claims description 8
- 235000019145 α-tocotrienol Nutrition 0.000 claims description 8
- 239000011730 α-tocotrienol Substances 0.000 claims description 8
- 239000002246 antineoplastic agent Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 229930003802 tocotrienol Natural products 0.000 description 3
- 239000011731 tocotrienol Substances 0.000 description 3
- 235000019148 tocotrienols Nutrition 0.000 description 3
- 229940068778 tocotrienols Drugs 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- GXJLQJFVFMCVHG-QXMHVHEDSA-N 2-methylpropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)C GXJLQJFVFMCVHG-QXMHVHEDSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4989485A JPS61210030A (ja) | 1985-03-13 | 1985-03-13 | 抗腫瘍剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4989485A JPS61210030A (ja) | 1985-03-13 | 1985-03-13 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61210030A JPS61210030A (ja) | 1986-09-18 |
| JPS6222966B2 true JPS6222966B2 (enExample) | 1987-05-20 |
Family
ID=12843732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4989485A Granted JPS61210030A (ja) | 1985-03-13 | 1985-03-13 | 抗腫瘍剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61210030A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2708126B2 (ja) * | 1987-08-25 | 1998-02-04 | 日清製粉株式会社 | イソプレノイド誘導体とそれを含有する抗潰瘍剤 |
| US5260294A (en) * | 1988-08-09 | 1993-11-09 | Hoffman-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
| US5015661A (en) * | 1988-08-09 | 1991-05-14 | Hoffmann-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
| US5132310A (en) * | 1988-08-09 | 1992-07-21 | Hoffmann-La Roche Inc. | Pharmacologically active chromanes |
| EP2143793B1 (en) * | 2007-03-27 | 2013-09-25 | Bridgestone Corporation | Genes of enzymes participating in vitamin e biosynthesis in para rubber tree |
-
1985
- 1985-03-13 JP JP4989485A patent/JPS61210030A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61210030A (ja) | 1986-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100387230C (zh) | 由大麻提取物制成的药物组合物 | |
| US4612194A (en) | Anti-rheumatic agents and their use | |
| US5908857A (en) | Agent for the treatment of infections | |
| JP5607013B2 (ja) | ユウリコマロンギフォリアの生理活性フラクション | |
| NL192204C (nl) | Werkwijze voor het bereiden van isosilybine-vrij silibinine en farmaceutisch preparaat dat isosilybine-vrij silibinine bevat. | |
| JPS6222966B2 (enExample) | ||
| US20220202890A1 (en) | Formulation containing cornus wilsoniana extract and use thereof | |
| JPH049331A (ja) | 肝機能改善剤 | |
| KR100577514B1 (ko) | 비페닐디메틸디카복실레이트, 및 카르두스 마리아누스추출물 또는 이로부터 정제된 실리빈을 함유하는 경구용마이크로에멀젼 조성물 | |
| JPH0647553B2 (ja) | 植物抽出物及びその用途 | |
| JP2540871B2 (ja) | 抗高脂血症剤 | |
| Faust et al. | The antineoplastic action of chemical fractions of the fruit of citrullus colocynthis on sarcoma‐37 | |
| CN102631397A (zh) | 一种改善脑部血液循环的中药组合物及其制备方法 | |
| JPH05246857A (ja) | 痴呆症治療剤 | |
| JPH10158184A (ja) | 細胞接着抑制剤 | |
| JPH07165588A (ja) | 脳機能改善剤 | |
| US12502371B2 (en) | Drug for treating and preventing dementia | |
| JP2008528562A (ja) | 薬物依存または薬物中毒の軽減 | |
| JPH09194368A (ja) | ポドフィロトキシン誘導体及びそれからなる新規細胞分化誘導剤 | |
| JPH07188039A (ja) | 抗ガストリン剤およびサブスタンスｐ拮抗剤 | |
| Murad et al. | Cardiac phospholipid composition during continuous administration of ethanol to mice: effect of vitamin E [proceedings] | |
| US4239756A (en) | Fatty aldehydes in the therapy of arteriosclerosis | |
| WO2018228430A1 (zh) | 异阿魏酸、含异阿魏酸中药提取物及升麻的用途 | |
| CN114096314A (zh) | 痴呆症的治疗和预防药 | |
| Zhang | Studies on traditional Chinese drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |